The dawn of 2026 has brought a renewed sense of hope to families affected by neurodegenerative diseases as genomic screening for Alzheimer’s and Parkinson’s risk becomes more widespread. New clinical guidelines emphasize that identifying genetic susceptibility in mid-life allows for the deployment of "neuro-protective" strategies, from specialized anti-inflammatory diets to...
Spanish 
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek